April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Clinical patterns of perfused central retinal vein occlusion: the initial presence of perivenular whitening shifts the balance between disc and macular edema
Author Affiliations & Notes
  • Michel Paques
    Clinical Investigation Center 503, Quinze-Vingts Hospital, INSERM, Paris, France
  • Alexandra Pierru
    Clinical Investigation Center 503, Quinze-Vingts Hospital, INSERM, Paris, France
    Ophthalmology, Hospital, Nice, France
  • Jean-François Girmens
    Clinical Investigation Center 503, Quinze-Vingts Hospital, INSERM, Paris, France
  • Footnotes
    Commercial Relationships Michel Paques, Imagine Eye (C), Merck Serono (C); Alexandra Pierru, None; Jean-François Girmens, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1079. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Michel Paques, Alexandra Pierru, Jean-François Girmens; Clinical patterns of perfused central retinal vein occlusion: the initial presence of perivenular whitening shifts the balance between disc and macular edema. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1079.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The highly heterogeneous presentations of central retinal vein occlusion (CRVO) has yet defied clinical modelling; this impairs the determination of an individual prognosis. We previously identified a peculiar presentation of acute CRVO defined by the presence of perivenular whitening (PVW), a feature most likely due to panretinal hypoperfusion (Paques and Gaudric, 2003). We then identified the inner nuclear layer as the anatomical site of PVW, which later on undergoes atrophy (Sarda et al, 2010). Subsequently, we found a high rate of disc edema in these patients which prompted us to further investigate the prognostic value of the initial presence of PVW on the anatomical outcome of CRVO.

Methods: The charts of 130 cases of recent-onset perfused CRVO with at least 3 months of follow-up seen in two centers were reviewed. The anatomical outcomes of those with (n=45) or without (n=85) evidence of PVW at inital examination were compared.

Results: In groups with and without PVW, mean age (48.9y vs 53.2y) were similar while there were more women in the group with PVW (58% versus 31%, p<0.05). Patients with PVW had a higher incidence of glaucoma (22% versus 11%) but a lower incidence of arterial hypertension (32% versus 66%). During follow-up, spotty or diffuse atrophy of the inner nuclear layer was exclusively observed in the PVW group. The incidence and topography of macular thickening differed between groups: eye with initial PVW developing macular thickening had more often fluorescein leakage from the disc (80%) than from the macula (15%); Accordingly, macular thickening predominated nasal to the fovea. By contrast, eyes without PVW were more prone to show leakage in the macula (77%) versus the disc (69%). Rates of rubeosis iridis were comparable.

Conclusions: Our findings suggest that, during perfused CRVO, the initial presence of PVW predicts to some extent the anatomical course. CRVO showing evidence of PVW are indeed more prone to develop atrophy of the inner nuclear layer and disc edema. The presence of PVW is also correlated with a peculiar profile of risk factors, raising the hypothesis that ocular perfusion pressure, which is lower in eyes with PVW, modulates the clinical presentation. Distinguishing disc from macular edema may be of interest for defining personnalized intravitreal injection regimen.

Keywords: 749 vascular occlusion/vascular occlusive disease • 461 clinical (human) or epidemiologic studies: natural history • 550 imaging/image analysis: clinical  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×